Get started
MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT)MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT)MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT)

MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

0JYL chart


Full chart

0JYL upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪12.69 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−2.468 USD
Net income (FY)
‪−141.41 M‬ USD
Revenue (FY)
‪30.99 M‬ USD
Shares float
‪41.87 M‬
Beta (1Y)
4.07

Employees


Employees (FY)
165
Change (1Y)
+14 +9.27%
Revenue / Employee (1Y)
‪187.81 K‬ USD
Net income / Employee (1Y)
‪−857.00 K‬ USD

About Marinus Pharmaceuticals, Inc.


Sector
Health Technology
CEO
Scott N. Braunstein
Headquarters
Radnor
Website
marinuspharma.com
Founded
2003
FIGI
BBG00JVRDZB0
Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded in August 2003 and is headquartered in Radnor, PA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0JYL news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 0JYL is 0.240 USD — it has decreased by −5.16% in the past 24 hours. Watch MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) stocks are traded under the ticker 0JYL.
0JYL stock has fallen by −7.72% compared to the previous week, the month change is a −21.38% fall, over the last year MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) has showed a −97.47% decrease.
We've gathered analysts' opinions on MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) future price: according to them, 0JYL price has a max estimate of 3.00 USD and a min estimate of 0.30 USD. Watch 0JYL chart and read a more detailed MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) stock forecast: see what analysts think of MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) and suggest that you do with its stocks.
0JYL reached its all-time high on Oct 4, 2018 with the price of 36.400 USD, and its all-time low was 0.234 USD and was reached on Dec 16, 2024. View more price dynamics on 0JYL chart.
See other stocks reaching their highest and lowest prices.
0JYL stock is 5.64% volatile and has beta coefficient of 4.07. Track MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) stock price on the chart and check out the list of the most volatile stocks — is MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) there?
Today MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) has the market capitalization of ‪12.69 M‬, it has decreased by −13.88% over the last week.
Yes, you can track MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) financials in yearly and quarterly reports right on TradingView.
MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) is going to release the next earnings report on Mar 11, 2025. Keep track of upcoming events with our Earnings Calendar.
0JYL earnings for the last quarter are −0.42 USD per share, whereas the estimation was −0.41 USD resulting in a −2.64% surprise. The estimated earnings for the next quarter are −0.30 USD per share. See more details about MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) earnings.
MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) revenue for the last quarter amounts to ‪8.54 M‬ USD, despite the estimated figure of ‪9.42 M‬ USD. In the next quarter, revenue is expected to reach ‪11.34 M‬ USD.
0JYL net income for the last quarter is ‪−24.23 M‬ USD, while the quarter before that showed ‪−35.83 M‬ USD of net income which accounts for 32.39% change. Track more MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) financial stats to get the full picture.
No, 0JYL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 165.00 employees. See our rating of the largest employees — is MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) EBITDA is ‪−122.09 M‬ USD, and current EBITDA margin is −422.52%. See more stats in MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) financial statements.
Like other stocks, 0JYL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) stock shows the sell signal. See more of MARINUS PHARMACEUTICALS INC COM USD0.001(POST REV SPLT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.